Latest From Lipocine Inc.
The latest drug development news and highlights from the Pink Sheet FDA Performance Tracker.
Keeping Track Of User Fee Decisions And Filings: Adakveo, Brukinsa And Fetroja Mark Massive Week Of Novel Approvals
The latest news on US FDA user fee decisions and submissions to the agency.
The latest drug development news and highlights from our US FDA Performance Tracker.
Studies are unfeasible, sponsors argue in advance of US advisory committee meeting that could lead to FDA ending its waiver on requiring clinical trials in pediatric patients for new testosterone replacement therapy products.
- Large Molecule
- Controlled Release
- Drug Delivery
- Therapeutic Areas
- Gynecological, Urological
- North America
- Parent & Subsidiaries
- Lipocine Inc.
- Senior Management
Mahesh V Patel, PhD, Pres. & CEO
Morgan Brown, EVP, CFO
Anthony Delconte, MD, CMO
Gregory Bass, Chief Commercial Officer
- Contact Info
Phone: (801) 994-7383
675 Arapeen Dr.
Salt Lake City, UT 84108
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.